These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34994112)

  • 1. Bacterial infections in cancer: A bilateral relationship.
    Basu A; Singh R; Gupta S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1771. PubMed ID: 34994112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-driven strategies to enhance the treatment of drug-resistant bacterial infections.
    Zhang J; Liu M; Guo H; Gao S; Hu Y; Zeng G; Yang D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1968. PubMed ID: 38772565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
    Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoids technology for advancing the clinical translation of cancer nanomedicine.
    Zhao DK; Liang J; Huang XY; Shen S; Wang J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1892. PubMed ID: 37088100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell membrane-coated nanoparticles for the treatment of bacterial infection.
    Ma J; Jiang L; Liu G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1825. PubMed ID: 35725897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive nanoplatforms for antibacterial applications.
    Huang Y; Zou L; Wang J; Jin Q; Ji J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microenvironment-regulating nanomedicine design to fight multi-drug resistant tumors.
    Xu Q; Lan X; Lin H; Xi Q; Wang M; Quan X; Yao G; Yu Z; Wang Y; Yu M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1842. PubMed ID: 35989568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy.
    Liao J; Jia Y; Wu Y; Shi K; Yang D; Li P; Qian Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1581. PubMed ID: 31429208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterials with active targeting as advanced antimicrobials.
    Smerkova K; Dolezelikova K; Bozdechova L; Heger Z; Zurek L; Adam V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1636. PubMed ID: 32363802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology intervention of the microbiome for cancer therapy.
    Song W; Anselmo AC; Huang L
    Nat Nanotechnol; 2019 Dec; 14(12):1093-1103. PubMed ID: 31802032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the mechanisms of silica nanoparticles for nanomedicine.
    Li Z; Mu Y; Peng C; Lavin MF; Shao H; Du Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1658. PubMed ID: 32602269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of vinyl polymer-based materials as nucleic acids carriers in cancer therapy.
    Pereira PA; Serra MES; Serra AC; Coelho JFJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1820. PubMed ID: 35637638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging antibacterial nanomedicine for enhanced antibiotic therapy.
    Wang S; Gao Y; Jin Q; Ji J
    Biomater Sci; 2020 Dec; 8(24):6825-6839. PubMed ID: 32996490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered bacteria: a new frontier in targeted drug delivery.
    Fooladi S; Rabiee N; Iravani S
    J Mater Chem B; 2023 Nov; 11(42):10072-10087. PubMed ID: 37873584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine and drug delivery systems in cancer and regenerative medicine.
    Garbayo E; Pascual-Gil S; Rodríguez-Nogales C; Saludas L; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1637. PubMed ID: 32351045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.
    Chen S; Yang K; Tuguntaev RG; Mozhi A; Zhang J; Wang PC; Liang XJ
    Nanomedicine; 2016 Feb; 12(2):269-86. PubMed ID: 26707818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.